Cited by 394Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

The DOI matches its Crossref record; 162 of the 166 references it cites were found in a registry or an index.

The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Madras, Bertha K., Miller, Gregory M., Fischman, Alan J.·2005·Biological Psychiatry

DOI 10.1016/j.biopsych.2004.10.011

Open this paper in CoChat — free account

Abstract

The high incidence of attention-deficit/hyperactivity disorder (ADHD) and escalating use of ADHD medications present a compelling case for clarifying the pathophysiology of, and developing laboratory or radiologic tests for, ADHD. Currently, the majority of specific genes implicated in ADHD encode components of catecholamine signaling systems. Of these, the dopamine transporter (DAT) is a principal target of the most widely used antihyperactivity medications (amphetamine and methylphenidate); the DAT gene is associated with ADHD, and some studies have detected abnormal levels of the DAT in brain striatum of ADHD subjects. Medications for ADHD interfere with dopamine transport by brain-region- and drug-specific mechanisms, indirectly activating dopamine- and possibly norepinephrine-receptor subtypes that are implicated in enhancing attention and experiential salience. The most commonly used DAT-selective ADHD medications raise extracellular dopamine levels in DAT-rich brain regions. In brain regions expressing both the DAT and the norepinephrine transporter (NET), the relative contributions of dopamine and norepinephrine to ADHD pathophysiology and therapeutic response are obfuscated by the capacity of the NET to clear dopamine as well as norepinephrine. Thus, ADHD medications targeting DAT or NET might disperse dopamine widely and consign dopamine storage and release to regulation by noradrenergic, as well as dopaminergic neurons.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2004.10.011

Cites

162 of 162 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Atomoxetine Increases Extracellular Levels of Norepinephrine and Dopamine in Prefrontal Cortex of Rat A Potential Mechanism for Efficacy in Attention Deficit/Hyperactivity Disorder
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman, L. S. (1998) · JAMA · doi:10.1001/jama.279.14.1100 · Cited by 1,082
Association of attention-deficit disorder and the dopamine transporter gene.
Cook, E. H., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., & LEVENTHAL, B. L. (1995) · PubMed · Cited by 995
Trace amines: Identification of a family of mammalian G protein-coupled receptors
Borowsky, B., Adham, N., JONES, K. A., Raddatz, R., Artymyshyn, R. P., Ogozalek, K. L., Durkin, M. M., Lakhlani, P. P., Bonini, J. A., Pathirana, S. M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151105198 · Cited by 912
Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature
Wilens, T. E., Faraone, S. V., Biederman, J., & Gunawardene, S. (2003) · Pediatrics · doi:10.1542/peds.111.1.179 · Cited by 872
Pharmacotherapy of Attention-Deficit Hyperactivity Disorder across the Life Cycle
SPENCER, T., BIEDERMAN, J., WILENS, T., HARDING, M., O'DONNELL, D., & GRIFFIN, S. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199604000-00008 · Cited by 830
Dopamine transporter density in patients with attention deficit hyperactivity disorder
Dougherty, D. D., Bonab, A. A., Spencer, T. J., Rauch, S. L., Madras, B. K., & Fischman, A. J. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04030-1 · Cited by 684
Self-citation
Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines
Morón, J. A., Brockington, A., Wise, R. A., Rocha, B. A., & Hope, B. T. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-02-00389.2002 · Cited by 681
Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Amphetamine, 3,4-Methylenedioxymethamphetamine, Lysergic Acid Diethylamide, and Metabolites of the Catecholamine Neurotransmitters Are Agonists of a Rat Trace Amine Receptor
Bunzow, J. R., Sonders, M. S., Arttamangkul, S., Harrison, L. M., Zhang, G., Quigley, D. I., Darland, T., Suchland, K. L., Pasumamula, S., Kennedy, J. L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.6.1181 · Cited by 651

Show all 166 references

Research works printed but not linked: 5

Barkley, 2001, vol. 9
Brown, 2001, Regulation of the vesicular monoamine transporter-2, J Pharmacol Exp Ther, 296, 762
DiMaio, 2003, Dopamine genes and attention-deficit hyperactivity disorder, J Psychiatry Neurosci, 28, 27
Galili-Weisstub, 2003, Attention deficit and hyperactivity disorder, Isr J Psychiatry Relat Sci, 40, 57
Goulet, 2000, Chronic methylphenidate treatment suppresses activity in more active juvenile monkeys and induces sleep disturbances, Soc Neurosci Abstracts, 26, 2177

Sorted by citations

Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Neurobiology of ADHD
Tripp, G., & Wickens, J. R. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.026 · Cited by 492
Measured Gene-Environment Interactions in Psychopathology: Concepts, Research Strategies, and Implications for Research, Intervention, and Public Understanding of Genetics
Moffitt, T. E., Caspi, A., & Rutter, M. (2006) · Perspectives on Psychological Science · doi:10.1111/j.1745-6916.2006.00002.x · Cited by 389
Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention?
Sonuga‐Barke, E. J. S., & Halperin, J. M. (2010) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2009.02195.x · Cited by 320
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Meta-Analysis: Treatment of Attention-Deficit/Hyperactivity Disorder in Children With Comorbid Tic Disorders
Bloch, M. H., Panza, K. E., Landeros-Weisenberger, A., & Leckman, J. F. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181b26e9f · Cited by 270
Effects of Methylphenidate on the Catecholaminergic System in Attention-Deficit/Hyperactivity Disorder
Wilens, T. E. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318173312f · Cited by 269
Potential adverse effects of amphetamine treatment on brain and behavior: a review
Berman, S. M., Kuczenski, R. T., McCracken, J. T., & London, E. D. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.90 · Cited by 263
Striatal dopamine transporter alterations in ADHD: pathophysiology or adaptation to psychostimulants? A meta-analysis
Fusar-Poli, P., Rubia, K., Rossi, G., Sartori, G., & Balottin, U. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2011.11060940 · Cited by 260
Dissociation in performance of children with ADHD and high-functioning autism on a task of sustained attention
Johnson, K. A., Robertson, I. H., Kelly, S. P., Silk, T. J., Barry, E., Dáibhis, A., Watchorn, A., Keavey, M., Fitzgerald, M., Gallagher, L., et al. (2007) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2007.02.019 · Cited by 259
Abuse of Amphetamines and Structural Abnormalities in the Brain
Berman, S. M., O’Neill, J., Fears, S. C., Bartzokis, G., & London, E. D. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1441.031 · Cited by 253
Brain dopamine transporter levels in treatment and drug naive adults with ADHD
Volkow, N. D., Wang, G.-J., Newcorn, J., Fowler, J. S., Telang, F., Solanto, M. V., Logan, J., Wong, C., Ma, Y., Swanson, J. M., et al. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2006.10.014 · Cited by 249
Attention-deficit-hyperactivity disorder and reward deficiency syndrome
Oscar Berman, M., Blum, K., Chen, T. J., Braverman, E., Waite, R., Downs, W., Arcuri, V., Notaro, A., Palomo, T., & Comings (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2627 · Cited by 248
“The same authors further showed from longitudinal evidence that these polymorphisms predicted which children with ADHD were at greatest risk for poor adult prognosis (also see Heiser et al 2004; Madras et al 2005; Larsson et al 2006).”
Background
Fetal programming of hypothalamic–pituitary–adrenal (HPA) axis function and behavior by synthetic glucocorticoids
Kapoor, A., Sophie Petropoulos, A., & Matthews, S. G. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.013 · Cited by 249
Neurocomputational models of basal ganglia function in learning, memory and choice
Cohen, M. X., & Frank, M. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.09.029 · Cited by 248
Clinically Relevant Doses of Methylphenidate Significantly Occupy Norepinephrine Transporters in Humans In Vivo
Hannestad, J., Gallezot, J.-D., Planeta-Wilson, B., Lin, S.-F., Williams, W. A., van Dyck, C. H., Malison, R. T., Carson, R. E., & Ding, Y.-S. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.017 · Cited by 236
Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder
Frank, M. J., Santamaria, A., O'Reilly, R. C., & Willcutt, E. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301278 · Cited by 227
Smoking, nicotine and neuropsychiatric disorders
Döme, P., Lazáry, J., Kalapos, M. P., & Rihmer, Z. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.013 · Cited by 227
The Evolution of Drug Development in Schizophrenia: Past Issues and Future Opportunities
Carpenter, W. T., & Koenig, J. I. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301639 · Cited by 218
Stimulus-dependent dopamine release in attention-deficit/hyperactivity disorder.
Sikström, S., & Söderlund, G. (2007) · Psychological Review · doi:10.1037/0033-295x.114.4.1047 · Cited by 205
Catecholamine Dysfunction in Attention-Deficit/Hyperactivity Disorder
Prince, J. B. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318174f92a · Cited by 214
Multidisciplinary perspectives on attention and the development of self-regulation
Berger, A., Kofman, O., Livneh, U., & Henik, A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.06.004 · Cited by 199
Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task
Bush, G., Spencer, T. J., Holmes, J., Shin, L. M., Valera, E. M., Seidman, L. J., Makris, N., Surman, C., Aleardi, M., Mick, E., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.16 · Cited by 201
The effects of physical activity on attention deficit hyperactivity disorder symptoms: The evidence
Gapin, J. I., Labban, J. D., & Etnier, J. L. (2011) · Preventive Medicine · doi:10.1016/j.ypmed.2011.01.022 · Cited by 221
Dopamine transporters govern diurnal variation in extracellular dopamine tone
Ferris, M. J., España, R. A., Locke, J. L., Konstantopoulos, J. K., Rose, J. H., Chen, R., & Jones, S. R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407935111 · Cited by 192
Neurogenetics and Pharmacology of Learning, Motivation, and Cognition
Frank, M. J., & Fossella, J. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.96 · Cited by 195
Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial
Moreau, C., Delval, A., Defebvre, L., Dujardin, K., Duhamel, A., Petyt, G., Vuillaume, I., Corvol, J., Brefel‐Courbon, C., Ory‐Magne, F., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70106-0 · Cited by 191
Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it?
Bozzi, Y., & Borrelli, E. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.01.002 · Cited by 187
In Vivo Neuroreceptor Imaging in Attention-Deficit/Hyperactivity Disorder: A Focus on The Dopamine Transporter
Spencer, T. J., Biederman, J., Madras, B. K., Faraone, S. V., Dougherty, D. D., Bonab, A. A., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.036 · Cited by 185
Self-citation
Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter
Salahpour, A., Ramsey, A., Medvedev, I., Kile, B. M., Sotnikova, T. D., Holmstrand, E., Ghisi, V., Nicholls, P., Wong, L., Murphy, K. L., et al. (2008) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0707646105 · Cited by 189
Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD
Franke, B., Vasquez, A. A., Johansson, S., Hoogman, M., Romanos, J., Boreatti-Hümmer, A., Heine, M., Jacob, C. P., Lesch, K.-P., Casas, M., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.170 · Cited by 183
Impact of the COMT Val108/158 Met and DAT genotypes on prefrontal function in healthy subjects
Caldú, X., Vendrell, P., Bartrés‐Faz, D., Clemente, I. C., Bargalló, N., Jurado, M. Á., Serra-Grabulosa, J. M., & Junqué, C. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.06.021 · Cited by 185
Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder
Buske-Kirschbaum, A., Schmitt, J., Plessow, F., Romanos, M., Weidinger, S., & Roessner, V. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.09.017 · Cited by 179
Morphological Abnormalities of the Thalamus in Youths With Attention Deficit Hyperactivity Disorder
Ivanov, I., Bansal, R., Hao, X., Zhu, H., Kellendonk, C., Miller, L., Sanchez-Pena, J., Miller, A. M., Chakravarty, M. M., Klahr, K., et al. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030398 · Cited by 172
Association of pyrethroid pesticide exposure with attention-deficit/hyperactivity disorder in a nationally representative sample of U.S. children
Wagner-Schuman, M. L., Richardson, J. R., Auinger, P., Braun, J. M., Lanphear, B. P., Epstein, J. N., Yolton, K. A., & Froehlich, T. E. (2015) · Environmental Health · doi:10.1186/s12940-015-0030-y · Cited by 162
Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease
Devos, D., Krystkowiak, P. C., Clement, F., Dujardin, K., Cottencin, O., Waucquier, N., Ajebbar, K., Thielemans, B., Kroumova, M., Duhamel, A., et al. (2006) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.100016 · Cited by 153
Regulation of monoamine transporters: Role of transporter phosphorylation
Ramamoorthy, S., Shippenberg, T. S., & Jayanthi, L. D. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.09.009 · Cited by 151
A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes I: general principles and overview
Chen, J., Férec, C., & Cooper, D. N. (2006) · Human Genetics · doi:10.1007/s00439-006-0180-7 · Cited by 147
Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder
Richardson, J. R., Taylor, M., Shalat, S. L., Guillot, T. S., Caudle, W. M., Hossain, M. M., Mathews, T. A., Jones, S. R., Cory‐Slechta, D. A., & Miller, G. W. (2015) · The FASEB Journal · doi:10.1096/fj.14-260901 · Cited by 148
Self-citation
The Placental Barrier: the Gate and the Fate in Drug Distribution
Tetro, N., Moushaev, S., Rubinchik-Stern, M., & Eyal, S. (2018) · Pharmaceutical Research · doi:10.1007/s11095-017-2286-0 · Cited by 145
Does the difference between physically active and couch potato lie in the dopamine system?
Knab, A. M., & Lightfoot, J. T. (2010) · International Journal of Biological Sciences · doi:10.7150/ijbs.6.133 · Cited by 148
Control of Extracellular Dopamine at Dendrite and Axon Terminals
Ford, C., Gantz, S. C., Phillips, P. E. M., & Williams, J. T. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.1020-10.2010 · Cited by 135
Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels
Kern, C. H., Stanwood, G. D., & Smith, D. R. (2009) · Synapse · doi:10.1002/syn.20736 · Cited by 136
Development and function of the midbrain dopamine system: what we know and what we need to
Bissonette, G. B., & Roesch, M. R. (2015) · Genes Brain & Behavior · doi:10.1111/gbb.12257 · Cited by 141
Low-Level Human Equivalent Gestational Lead Exposure Produces Sex-Specific Motor and Coordination Abnormalities and Late-Onset Obesity in Year-Old Mice
Leasure, J. L., Giddabasappa, A., Chaney, S., Johnson, J. E., Pothakos, K., Lau, Y., & Fox, D. A. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10862 · Cited by 130
Dimensional Analysis of ADHD Subtypes in Rats
Blondeau, C., & Dellu-Hagedorn, F. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.06.030 · Cited by 129
Attention deficit/hyperactivity disorder: a focused overview for children’s environmental health researchers
Aguiar, A., Eubig, P. A., & Schantz, S. L. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002326 · Cited by 125
Early life protein restriction alters dopamine circuitry
Vucetic, Z., Totoki, K., Schoch, H., Whitaker, K. W., Hill‐Smith, T. E., Lucki, I., & Reyes, T. M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.010 · Cited by 119
Caffeine Regulates Frontocorticostriatal Dopamine Transporter Density and Improves Attention and Cognitive Deficits in an Animal Model of Attention Deficit Hyperactivity Disorder
Pandolfo, P., Machado, N. J., Köfalvi, A., Takahashi, R. N., & Cunha, R. A. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.04.011 · Cited by 118
Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease
Devos, D., Defebvre, L., & Bordet, R. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2009.00798.x · Cited by 117
History of the Discovery of the Antipsychotic Dopamine D2 Receptor: A Basis for the Dopamine Hypothesis of Schizophrenia
Madras, B. K. (2013) · Journal of the History of the Neurosciences · doi:10.1080/0964704x.2012.678199 · Cited by 116
Self-citation
Origins of altered reinforcement effects in ADHD
Johansen, E., Killeen, P. R., Russell, V. A., Tripp, G., Wickens, J. R., Tannock, R., Williams, J., & Sagvolden, T. (2009) · Behavioral and Brain Functions · doi:10.1186/1744-9081-5-7 · Cited by 108
Methylphenidate improves deficient error evaluation in children with ADHD; an event-related brain potential study
Jonkman, L. M., van Melis, J. J. M., Kemner, C., & Markus, C. R. (2007) · Biological Psychology · doi:10.1016/j.biopsycho.2007.08.004 · Cited by 111
An atlas of transcriptionally defined cell populations in the rat ventral tegmental area
Phillips, R. A., Tuscher, J. J., Black, S. L., Andraka, E., Fitzgerald, N. D., Ianov, L., & Day, J. J. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110616 · Cited by 119
SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder
Krause, J. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.4.611 · Cited by 110
A Comprehensive In Vitro Screening of d-, l- , and dl-threo -Methylphenidate: An Exploratory Study
Markowitz, J. S., DeVane, C. L., Pestreich, L. K., Patrick, K. S., & Muniz, R. (2006) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.16.687 · Cited by 109
Review of rodent models of attention deficit hyperactivity disorder
Regan, S. L., Williams, M. T., & Vorhees, C. V. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.11.041 · Cited by 113
Prediction of Heterogeneity in Intelligence and Adult Prognosis by Genetic Polymorphisms in the Dopamine System Among Children With Attention-Deficit/Hyperactivity Disorder
Mill, J. S., Caspi, A., Williams, B. S., Craig, I., Taylor, A., Polo-Tomás, M., Berridge, C. W., Poulton, R., & Moffitt, T. E. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.4.462 · Cited by 104
Increased impulsive behavior and risk proneness following lentivirus-mediated dopamine transporter over-expression in rats' nucleus accumbens
Adriani, W., Boyer, F., Gioiosa, L., Macrì, S., Dreyer, J.-L., & Laviola, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.11.042 · Cited by 97
Over-the-counter analgesics during pregnancy: a comprehensive review of global prevalence and offspring safety
Zafeiri, A., Mitchell, R. T., Hay, D. C., & Fowler, P. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa042 · Cited by 100
Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: Current status and working hypotheses
Vaidya, C. J., & Stollstorff, M. (2008) · Developmental Disabilities Research Reviews · doi:10.1002/ddrr.40 · Cited by 95
Smoking during pregnancy and hyperactivity-inattention in the offspring--comparing results from three Nordic cohorts
Obel, C., Línnet, K., Henriksen, T. B., Rodriguez, A., Järvelin, M., Kotimaa, A., Moilanen, I. K., Ebeling, H., Bilenberg, N., Taanila, A. M., et al. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dym290 · Cited by 95
Electrophysiological evidence of atypical motivation and reward processing in children with attention-deficit hyperactivity disorder
Holroyd, C. B., Baker, T. E., Kerns, K. A., & Müller, U. (2008) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2008.02.011 · Cited by 93
Epigenetics in Developmental Disorder: ADHD and Endophenotypes
Archer, T., & Oscar‐Berman, M. (2011) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000104 · Cited by 94
Altered dopaminergic profiles: Implications for the regulation of voluntary physical activity
Knab, A. M., Bowen, R. S., Hamilton, A., Gulledge, A. A., & Lightfoot, J. T. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.05.034 · Cited by 91
Handbook of Reward and Decision Making
Dreher, J., & Tremblay, L. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374620-7.x0001-5 · Cited by 88
Coffee consumption during pregnancy and the risk of hyperkinetic disorder and ADHD: a prospective cohort study
Linnet, K. M., Wisborg, K., Secher, N. J., Hove Thomsen, P., Obel, C., Dalsgaard, S., & Henriksen, T. B. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2008.00980.x · Cited by 87
Trace Amine-Associated Receptor 1 Displays Species-Dependent Stereoselectivity for Isomers of Methamphetamine, Amphetamine, and Para-Hydroxyamphetamine
Reese, E. A., Bunzow, J. R., Arttamangkul, S., Sonders, M. S., & Grandy, D. K. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.115402 · Cited by 88
Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD
Krause, J., la Fougere, C., Krause, K.-H., Ackenheil, M., & Dresel, S. H. (2005) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-005-0602-x · Cited by 84
Transgenic mouse models for ADHD
Leo, D., & Gainetdinov, R. R. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1639-1 · Cited by 86
ADHD related behaviors are associated with brain activation in the reward system
Stark, R., Bauer, E., Merz, C. J., Zimmermann, M., Reuter, M., Plichta, M. M., Kirsch, P., Lesch, K. P., Fallgatter, A. J., Vaitl, D., et al. (2011) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.12.012 · Cited by 82
The Neurobiology of Binge-eating Disorder Compared with Obesity: Implications for Differential Therapeutics
Boswell, R. G., Potenza, M. N., & Grilo, C. M. (2020) · Clinical Therapeutics · doi:10.1016/j.clinthera.2020.10.014 · Cited by 89
Association and linkage of allelic variants of the dopamine transporter gene in ADHD
Friedel, S., Saar, K., Sauer, S., Dempfle, A., Walitza, S., Renner, T., Romanos, M., Freitag, C. M., Seitz, C., Pálmason, H., et al. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001986 · Cited by 80
Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood
Nemoda, Z., Szekely, A., & Sasvari-Szekely, M. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.04.002 · Cited by 78
Association of the dopamine transporter (SLC6A3/DAT1) gene 9–6 haplotype with adult ADHD
Franke, B., Hoogman, M., Arias Vasquez, A., Heister, J. G. A. M., Savelkoul, P. J., Naber, M., Scheffer, H., Kiemeney, L. A., Kan, C. C., Kooij, J. J. S., et al. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30861 · Cited by 77
Social Behavior and Skills in Children
Matson, J. L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0234-4 · Cited by 79
Sex differences in corticolimbic dopamine and serotonin systems in the rat and the effect of postnatal handling
Duchesne, A., Dufresne, M. M., & Sullivan, R. M. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.11.012 · Cited by 75
Differential Pharmacokinetics and Pharmacodynamics of Methylphenidate Enantiomers
Markowitz, J. S., & Patrick, K. S. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181733560 · Cited by 74
The dopamine transporter role in psychiatric phenotypes
Salatino‐Oliveira, A., Rohde, L. A., & Hutz, M. H. (2017) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32578 · Cited by 73
Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression
Calipari, E. S., Ferris, M. J., Salahpour, A., Caron, M. G., & Jones, S. R. (2013) · Nature Communications · doi:10.1038/ncomms3720 · Cited by 72
Food allergy and food‐based therapies in neurodevelopmental disorders
de Theije, C. G. M., Bavelaar, B. M., da Silva, S. L., Korte, S. M., Olivier, B., Garssen, J., & Kraneveld, A. D. (2013) · Pediatric Allergy and Immunology · doi:10.1111/pai.12149 · Cited by 71
Sex differences in attentional processes in adult rats as measured by performance on the 5-choice serial reaction time task
Bayless, D. W., Darling, J. S., Stout, W. J., & Daniel, J. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.028 · Cited by 71
Effects of Ethanol Exposure During Early Pregnancy in Hyperactive, Inattentive and Impulsive Behaviors and MeCP2 Expression in Rodent Offspring
Kim, P., Park, J., Choi, C. S., Choi, I., Joo, S. H., Kim, M. K., Kim, S. Y., Kim, K. C., Park, S. H., Kwon, K. J., et al. (2013) · Neurochemical Research · doi:10.1007/s11064-012-0960-5 · Cited by 71
Causal Factors of Increased Smoking in ADHD: A Systematic Review
van Amsterdam, J., van der Velde, B., Schulte, M. H. J., & van den Brink, W. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1334066 · Cited by 70
Medial prefrontal gray matter volume reductions in users of amphetamine-type stimulants revealed by combined tract-based spatial statistics and voxel-based morphometry
Daumann, J., Koester, P., Becker, B., Wagner, D. R., Imperati, D., Gouzoulis‐Mayfrank, E., & Tittgemeyer, M. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.08.065 · Cited by 71
The Structure and Function of the Dopamine Transporter and its Role in CNS Diseases
McHugh, P., & Buckley, D. A. (2015) · Vitamins and hormones · doi:10.1016/bs.vh.2014.12.009 · Cited by 76
Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder
Hesse, S., Ballaschke, O., Barthel, H., & Sabri, O. (2009) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2008.01.002 · Cited by 70
Does environmental exposure to the greenhouse gas, N 2 O, contribute to etiological factors in neurodevelopmental disorders? A mini-review of the evidence
Fluegge, K. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.08.013 · Cited by 68
SUICIDE RISK IN ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Giupponi, G., Giordano, G., Maniscalco, I., Erbuto, D., Berardelli, I., Conca, A., Lester, D., Girardi, P., & Pompili, M. (2018) · Psychiatria Danubina · doi:10.24869/psyd.2018.2 · Cited by 66
A dopamine transporter polymorphism is a risk factor for borderline personality disorder in depressed patients
Joyce, P. R., McHugh, P., McKenzie, J. M., Sullivan, P. F., Mulder, R., Luty, S. E., Carter, J. D., FRAMPTON, C. M. A., Cloninger, C. R., MILLER, A. M., et al. (2006) · Psychological Medicine · doi:10.1017/s0033291706007288 · Cited by 65
A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD
Rommelse, N. N. J., Altink, M. E., Vásquez, A. A., Buschgens, C. J. M., Fliers, E. A., Faraone, S. V., Buitelaar, J. K., Sergeant, J. A., Franke, B., & Oosterlaan, J. (2008) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30848 · Cited by 64
ADHD and hyperkinetic disorder
Sonuga‐Barke, E. J. S., & Taylor, E. (2015) · Rutter's Child and Adolescent Psychiatry · doi:10.1002/9781118381953.ch55 · Cited by 62
The spontaneously hypertensive and Wistar Kyoto rat models of ADHD exhibit sub-regional differences in dopamine release and uptake in the striatum and nucleus accumbens
Miller, E. M., Pomerleau, F., Huettl, P. F., Russell, V. A., Gerhardt, G. A., & Glaser, P. E. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.020 · Cited by 62
Hyperactivity in the rat is associated with spontaneous low level of n-3 polyunsaturated fatty acids in the frontal cortex
Vancassel, S., Blondeau, C., Lallemand, S.-M., Cador, M., Linard, A., Lavialle, M., & Dellu-Hagedorn, F. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.02.032 · Cited by 61
Resting-State Striato-Frontal Functional Connectivity is Sensitive to DAT1 Genotype and Predicts Executive Function
Gordon, E. M., Devaney, J. M., Bean, S. E., & Vaidya, C. J. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht229 · Cited by 63
Differentiating Physicochemical Properties between Addictive and Nonaddictive ADHD Drugs Revealed by Molecular Dynamics Simulation Studies
Wang, P., Zhang, X., Fu, T., Li, S., Li, B., Xue, W., Yao, X., Chen, Y., & Zhu, F. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00173 · Cited by 60
Positron emission tomography neuroimaging for a better understanding of the biology of ADHD
Zimmer, L. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.08.001 · Cited by 63
LPHN3 and attention‐deficit/hyperactivity disorder: interaction with maternal stress during pregnancy
Choudhry, Z., Sengupta, S. M., Grizenko, N., Fortier, M., Thakur, G. A., Bellingham, J., & Joober, R. (2012) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2012.02551.x · Cited by 61
Effect of dopamine transporter gene (SLC6A3) variation on dorsal anterior cingulate function in attention‐deficit/hyperactivity disorder
Brown, A., Biederman, J., Valera, E. M., Doyle, A. E., Bush, G., Spencer, T. J., Monuteaux, M. C., Mick, E. O., Whitfield, S., Makris, N., et al. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31022 · Cited by 56
Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder
Lepping, P., & Huber, M. K. (2010) · CNS Drugs · doi:10.2165/11537610-000000000-00000 · Cited by 55

Authors: Madras, B. K., Miller, G. M., & Fischman, A. J.
Affiliations: Harvard University (US)
Massachusetts General Hospital (US)
Corresponding author: Madras, Bertha K.
ORCID: Madras, Bertha K.
Miller, Gregory M.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2005-06
Volume: 57
Issue: 11
Pages: 1397-1409
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2004.10.011
OpenAlex: W2011083427
Cited by: 393
References: 166
Citations by year: 2026: 10 · 2025: 20 · 2024: 9 · 2023: 13 · 2022: 11 · 2021: 12 · 2020: 18 · 2019: 10 · 2018: 11 · 2017: 11 · 2016: 14 · 2015: 15 · 2014: 23 · 2013: 16 · 2012: 27
FWCI: 4.54
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA 06303, R01DA011558, K05DA015305, DA15305, DA 11558)
National Center for Research Resources (RR00 168)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords: dopamine transporter, attention deficit hyperactivity disorder, ADHD pathophysiology, catecholamine signaling, norepinephrine transporter, amphetamine, methylphenidate, striatum, dopamine, norepinephrine, ADHD medication, genetic susceptibility
MeSH terms: Adaptation, Physiological, Central Nervous System Stimulants, Animals, Attention Deficit Disorder with Hyperactivity, Diagnostic Imaging, Humans, Membrane Glycoproteins, Mutation, Nerve Tissue Proteins, Genetic Variation, Membrane Transport Proteins, Dopamine Plasma Membrane Transport Proteins, Vesicular Biogenic Amine Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Dopamine Transporter and Attention-Deficit/Hyperactivity Disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks